Skip to content
healthcare.dev
Get a free key

Solifenacin Succinate

NDC 67184-0517, Solifenacin Succinate Tablets, tablet, film coated, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0517
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209333
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0517 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SOLIFENACIN SUCCINATE10 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
67184-0517-16718405170130 TABLET, FILM COATED in 1 BOTTLE (67184-0517-1)
67184-0517-26718405170290 TABLET, FILM COATED in 1 BOTTLE (67184-0517-2)
67184-0517-3671840517032000 TABLET, FILM COATED in 1 BOTTLE (67184-0517-3)
67184-0517-46718405170440 TABLET, FILM COATED in 1 BLISTER PACK (67184-0517-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 67184-0517 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0517 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.